Skip to content

Ultrasound-Guided Serratus Anterior Plane Block with Low Concentrations of Ropivacaine Combined with Dexmedetomidine for Postoperative Analgesia in modified radical mastectomy.

Ultrasound-Guided Serratus Anterior Plane Block with Low Concentrations of Ropivacaine Combined with Dexmedetomidine for Postoperative Analgesia in modified radical mastectomy.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071444
Enrollment
Unknown
Registered
2023-05-16
Start date
2023-05-16
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group R:Serratus anterior plane block (ropivacaine)
Group RD0.5:Serratus anterior plane block (Ropivacaine and dexmedetomidine 0.5ug/kg)
RD1.0:Serratus anterior plane block (Ropivacaine and dexmedetomidine1.0ug/kg)

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. BMI 18-28kg/m2. 2. Patients who are scheduled to undergo modified radical mastectomy. 3. ASA I-III. 4. The patient or an authorized relative signed the informed consent. 5. Have completed the auxiliary examination of admission.

Exclusion criteria

Exclusion criteria: 1. There are contraindications for nerve block, such as coagulation dysfunction, infection at the puncture site, and refusal of nerve block by the patient. 2. Preoperative concomitant cognitive dysfunction. 3. A variety of reasons, such as visual impairment, hearing impairment, mental illness, etc., may not be sufficient to complete the postoperative assessment. 4. Present with sick sinus syndrome and/or basal heart rate less than 50 beats per minute. 5. History of allergy to dexmedetomidine and ropivacaine. 6. Complicated with serious cardiopulmonary dysfunction, liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
Area under the curve of numerical scores of pain intensity within 24 hours.;

Secondary

MeasureTime frame
The time of first analgesic relief;Morphine analgesic remediation consumption in PCA;Postoperative sedation level;Incidence of perioperative bradycardia and hypotension.;Incidence of moderate or higher pain within 24 hours after surgery and the highest value of the NRS;Adverse ;Preoperative and postoperative 24 hours of QoR-15 scale scores.;

Countries

china

Contacts

Public ContactKejian Shi

The First Affiliated Hospital of Wenzhou Medical University

wzshikejian@163.com+86 138 6888 9697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026